FDA Inspection
DLC Laboratories, IncDLC Laboratories, Inc – FDA Inspection, Mar 30, 2018
Record Details
This FDA Inspection record concerns DLC Laboratories, Inc, with an inspection on March 30, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 2efe6fba-9206-4d0c-857e-1afb8b0f93c1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1046262
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.142(b)Storage under appropriate conditions
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.166(a)(2)Stability sample storage conditions described
- 21 CFR 211.67(b)Written procedures fail to include
Full citation text and observation details available on the Dashboard.
Other FDA inspections of DLC Laboratories, Inc
7| Date | Classification | Office | Project area |
|---|---|---|---|
| January 31, 2025 | VAI | Los Angeles District Office | Drug Quality Assurance |
| December 12, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 11, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 3, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 3, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for DLC Laboratories, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.